Exploratory observational study of the effects of EGFR-TKIs on NLRs

Exploratory observational study of the effects of EGFR-TKIs on NLRs - Exploratory observational study of the effects of EGFR-TKIs on NLRs

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046072

Enrollment

120

Registered

2021-11-15

Start date

2021-11-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

EGFR+ NSCLC

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) NSCLC Adeno 2) Stage III/IV + After Ope 3) EGFR+ (Ex19del or L858R) 4) Locally Advanced or Metastatic Chemo Naive 5) Age>=20 6)PS:0-2 7) Not double cancer 8)Sufficient function(Liver,Kidney,CV) 9)EGFR-TKI started 2/1/2015-1/31/2020

Exclusion criteria

Exclusion criteria: Not Eligible

Design outcomes

Primary

Measure	Time frame
Relaiton of NLR and ORR/PFS	—

Secondary

Measure	Time frame
Relation of NLR and OS	—

Countries

Japan

Contacts

Public ContactHiroshige Yoshioka

Kansai Medical University Department of Respiratory Oncology

hgyoshioka@gmail.com0728040101

Outcome results